Special items: Ovarian Cancer and Us blog best viewed in Firefox

Wednesday, March 24, 2010

Merck KGaA halts cancer vaccine trial - MarketWatch

"STRIDE is a randomized, double-blind, controlled, multi-center Phase III study designed to determine if Stimuvax can extend progression free survival in patients treated with hormonal therapy who have inoperable, locally advanced, recurrent or metastatic breast cancer."

No comments:

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.